223 related articles for article (PubMed ID: 34738596)
1. Prolactin Level in Polycystic Ovary Syndrome (PCOS): An approach to the diagnosis and management.
Davoudi Z; Araghi F; Vahedi M; Mokhtari N; Gheisari M
Acta Biomed; 2021 Nov; 92(5):e2021291. PubMed ID: 34738596
[TBL] [Abstract][Full Text] [Related]
2. What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome?
Kim SI; Yoon JH; Park DC; Yang SH; Kim YI
Int J Med Sci; 2023; 20(4):463-467. PubMed ID: 37057215
[No Abstract] [Full Text] [Related]
3. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
4. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
5. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
[TBL] [Abstract][Full Text] [Related]
6. [Misleading diagnosis of hyperprolactinemia in women].
Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
[TBL] [Abstract][Full Text] [Related]
7. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
Lu CC; Hsieh CJ
Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Macroprolactin in Hyperprolactinemia.
Sherazi NA; Baig MZ; Khan AH
J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
[TBL] [Abstract][Full Text] [Related]
10. [Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2004 Oct; 17(100):385-7. PubMed ID: 15690710
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinemia in children during the peripubertal period--personal observations.
Noczyńska A; Wasikowa R
J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1399-404. PubMed ID: 15526718
[TBL] [Abstract][Full Text] [Related]
12. Determination of the frequency of hyperprolactinemia-related etiologies and the etiology-specific mean prolactin levels.
Korkmaz FN; Gökçay Canpolat A; Şahin M; Çorapçioğlu D
Minerva Endocrinol (Torino); 2021 Sep; ():. PubMed ID: 34528777
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.
Su HW; Chen CM; Chou SY; Liang SJ; Hsu CS; Hsu MI
Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100
[TBL] [Abstract][Full Text] [Related]
14. [Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?].
Robin G; Catteau-Jonard S; Young J; Dewailly D
Gynecol Obstet Fertil; 2011 Mar; 39(3):141-5. PubMed ID: 21388855
[TBL] [Abstract][Full Text] [Related]
15. Etiological diagnosis of hyperprolactinemia.
Cortet-Rudelli C; Sapin R; Bonneville JF; Brue T
Ann Endocrinol (Paris); 2007 Jun; 68(2-3):98-105. PubMed ID: 17524347
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
[TBL] [Abstract][Full Text] [Related]
17. Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.
Chutpiboonwat P; Yenpinyosuk K; Sridama V; Kunjan S; Klaimukh K; Snabboon T
Pan Afr Med J; 2020; 36():8. PubMed ID: 32550971
[TBL] [Abstract][Full Text] [Related]
18. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia.
Sharma LK; Dutta D; Sharma N; Kulshreshtha B; Lal S; Sethi R
J Lab Physicians; 2021 Dec; 13(4):353-357. PubMed ID: 34975255
[No Abstract] [Full Text] [Related]
20. Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome.
Escobar-Morreale HF
Fertil Steril; 2004 Dec; 82(6):1697-9. PubMed ID: 15589886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]